Vikasa decreased its stake in Anondita Healthcare from 2.12% to 1.14%, reducing its holding by 1,67,600 shares.
A personal care manufacturer specializing in flavored male contraceptive products, Anondita Medi produces condoms under its flagship COBRA brand. Founded in 2024, the company operates in the niche segment of flavored contraceptives within India's broader sexual wellness and personal care market. Its distinctive approach targets evolving consumer preferences for enhanced intimate experiences through innovative product formulation, design, and strategic branding in the contraceptive category.
Mumbai-based (Vikasa India EIF I Fund) and one of India's most active SME-IPO anchor investors, with 87 SME IPO anchor positions across infrastructure, chemicals, electrical equipment, steel, textiles, IT and logistics.
